Molecular Cancer Therapeutics · 2012 · 35 citations · 25 references
MedicineOncologyPharmacologyApoptosisMolecular OncologySignal TransductionApoptosis In CancerApoptosis PharmacologyApoptosis ResistanceCancer Cell SignalingGlycolysis RegulationSignal Transduction In CancerAntiapoptotic Protein RegulationAnticancer ActivityAnticancer ChemotherapyApoptosis TargetingNf-κb SignalingSurvivin InhibitionTrail ReceptorsTrail-mediated Apoptosis
Methylglyoxal is an essential component in glycolysis and is known to be an inducer of apoptosis. Glyoxalase I (GLO1) metabolizes and inactivates methylglyoxal. GLO1 is known to be overexpressed in cancer cells and causes resistance to anticancer agents. We show for the first time that methylglyoxal treatment or the silencing of GLO1 enhances sensitivity to the promising anticancer agent TRAIL in malignant tumor cells. Methylglyoxal suppressed the expression of antiapoptotic factors, X-linked inhibitor of apoptosis protein (XIAP), survivin, cIAP1, Bcl-2, and Bcl-xL, without affecting TRAIL receptors, DR4 and DR5. Knockdown of XIAP or survivin by siRNA also enhanced TRAIL-induced apoptosis, indicating that downregulation of XIAP and survivin expression by methylglyoxal contributes to the enhancement of TRAIL activity. Furthermore, methylglyoxal decreased NF-κB activity with or without TRAIL treatment. On the other hand, the knockdown of GLO1 by siRNA enhanced TRAIL-induced apoptosis via the downregulation of XIAP and survivin expression. In conclusion, our results strongly suggest that sensitivity to TRAIL is increased by inhibition of the glyoxalase pathway and that the combination of TRAIL with methylglyoxal or glyoxalase inhibitors may be useful for a novel combination chemotherapy.
25
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
Henning Walczak, Robert E. Miller, K. Ariail et al. · Nature Medicine · 1999 · 2.5K citations
Safety and antitumor activity of recombinant soluble Apo2 ligand
Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Christian Stehlik, Rainer de Martin, Ichiro Kumabashiri et al. · The Journal of Experimental Medicine · 1998 · 634 citations · Full text
THE MECHANISM OF ACTION OF GLYOXALASE
E. Racker · Journal of Biological Chemistry · 1951 · 581 citations · Full text